Coeptis Therapeutics announces rebranding to Coeptis

“Coeptis Therapeutics (COEP) is excited to announce its rebranding to Coeptis, marking a transformative shift in its business strategy. This pivotal change reflects our commitment to expanding beyond biopharmaceuticals and embracing diverse growth opportunities in technology-driven sectors. With the establishment of our new Technology Division, Coeptis aims to enhance operational capabilities and maximize shareholder value. Central to this initiative was the recent acquisition of the NexGenAI Affiliates Network platform, a groundbreaking AI-powered marketing solution. This acquisition aligns seamlessly with Coeptis’s mission to innovate in highly regulated industries, revolutionizing marketing strategies and operational efficiencies.”